Physician profile
Michael P Grimes
NPI 1104083971
$5,248.26
in general payments reported to CMS, 2019-2025
14 companies · $4,893 in 2025
The $4,893 reported for 2025 was more than what 97% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $73.70 · 2023: $28.60 · 2024: $17.36 · 2025: $4,893.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,500 · Food and Beverage: $234 · Travel and Lodging: $205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,500.00 |
| Food and Beverage | $233.60 |
| Travel and Lodging | $205.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,846.39 | 2025 | |
| Abbvie INC. | $113.40 | 2019-2023 | |
| Lupin INC. | $46.80 | 2019-2020 | |
| Covidien LP | $40.08 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $35.47 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $29.32 | 2019 | |
| Meditrina | $24.22 | 2025 | |
| Organon LLC | $22.13 | 2025 | Jada System |
| Mission Pharmacal Company | $21.37 | 2020 | |
| Hologic Sales and Service, LLC | $17.36 | 2024 | Aptima |
| Amag Pharmaceuticals, INC. | $13.93 | 2019 | |
| Medtronic Vascular, INC. | $12.99 | 2019 | |
| Pfizer INC. | $12.86 | 2019 | |
| Coopersurgical, INC. | $11.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Grimes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.